429 related articles for article (PubMed ID: 18843795)
41. Senescence-Like Phenotypes in Human Nevi.
Joselow A; Lynn D; Terzian T; Box NF
Methods Mol Biol; 2017; 1534():175-184. PubMed ID: 27812879
[TBL] [Abstract][Full Text] [Related]
42. p16
Al-Khalaf HH; Aboussekhra A
Mol Carcinog; 2017 Mar; 56(3):985-999. PubMed ID: 27596953
[TBL] [Abstract][Full Text] [Related]
43. p53 and p16(INK4A) independent induction of senescence by chromatin-dependent alteration of S-phase progression.
Prieur A; Besnard E; Babled A; Lemaitre JM
Nat Commun; 2011 Sep; 2():473. PubMed ID: 21915115
[TBL] [Abstract][Full Text] [Related]
44. Genome-Wide Overexpression Screen Identifies Genes Able to Bypass p16-Mediated Senescence in Melanoma.
Lee WJ; Škalamera D; Dahmer-Heath M; Shakhbazov K; Ranall MV; Fox C; Lambie D; Stevenson AJ; Yaswen P; Gonda TJ; Gabrielli B
SLAS Discov; 2017 Mar; 22(3):298-308. PubMed ID: 27872202
[TBL] [Abstract][Full Text] [Related]
45. Functional impairment of p16(INK4A) due to CDKN2A p.Gly23Asp missense mutation.
Scaini MC; Rossi E; de Siqueira Torres PL; Zullato D; Callegaro M; Casella C; Quaggio M; Agata S; Malacrida S; Chiarion-Sileni V; Vecchiato A; Alaibac M; Montagna M; Mann GJ; Menin C; D'Andrea E
Mutat Res; 2009 Dec; 671(1-2):26-32. PubMed ID: 19712690
[TBL] [Abstract][Full Text] [Related]
46. Contribution of p16(INK4a) to replicative senescence of human fibroblasts.
Brookes S; Rowe J; Gutierrez Del Arroyo A; Bond J; Peters G
Exp Cell Res; 2004 Aug; 298(2):549-59. PubMed ID: 15265701
[TBL] [Abstract][Full Text] [Related]
47. Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
Gray-Schopfer VC; Cheong SC; Chong H; Chow J; Moss T; Abdel-Malek ZA; Marais R; Wynford-Thomas D; Bennett DC
Br J Cancer; 2006 Aug; 95(4):496-505. PubMed ID: 16880792
[TBL] [Abstract][Full Text] [Related]
48. Mutation testing in melanoma families: INK4A, CDK4 and INK4D.
Newton Bishop JA; Harland M; Bennett DC; Bataille V; Goldstein AM; Tucker MA; Ponder BA; Cuzick J; Selby P; Bishop DT
Br J Cancer; 1999 Apr; 80(1-2):295-300. PubMed ID: 10390011
[TBL] [Abstract][Full Text] [Related]
49. Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16(ink4a).
Kosar M; Bartkova J; Hubackova S; Hodny Z; Lukas J; Bartek J
Cell Cycle; 2011 Feb; 10(3):457-68. PubMed ID: 21248468
[TBL] [Abstract][Full Text] [Related]
50. Upregulation of p16INK4A promotes cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients.
Gu Z; Cao X; Jiang J; Li L; Da Z; Liu H; Cheng C
Cell Signal; 2012 Dec; 24(12):2307-14. PubMed ID: 22820504
[TBL] [Abstract][Full Text] [Related]
51. H3K9me-enhanced DNA hypermethylation of the p16INK4a gene: an epigenetic signature for spontaneous transformation of rat mesenchymal stem cells.
Zheng Y; He L; Wan Y; Song J
Stem Cells Dev; 2013 Jan; 22(2):256-67. PubMed ID: 22873822
[TBL] [Abstract][Full Text] [Related]
52. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.
Soufir N; Bressac-de Paillerets B; Desjardins L; Lévy C; Bombled J; Gorin I; Schlienger P; Stoppa-Lyonnet D
Br J Cancer; 2000 Feb; 82(4):818-22. PubMed ID: 10732752
[TBL] [Abstract][Full Text] [Related]
53. Aging of mice is associated with p16(Ink4a)- and β-galactosidase-positive macrophage accumulation that can be induced in young mice by senescent cells.
Hall BM; Balan V; Gleiberman AS; Strom E; Krasnov P; Virtuoso LP; Rydkina E; Vujcic S; Balan K; Gitlin I; Leonova K; Polinsky A; Chernova OB; Gudkov AV
Aging (Albany NY); 2016 Jul; 8(7):1294-315. PubMed ID: 27391570
[TBL] [Abstract][Full Text] [Related]
54. The atr protein kinase controls UV-dependent upregulation of p16INK4A through inhibition of Skp2-related polyubiquitination/degradation.
Al-Khalaf HH; Hendrayani SF; Aboussekhra A
Mol Cancer Res; 2011 Mar; 9(3):311-9. PubMed ID: 21270107
[TBL] [Abstract][Full Text] [Related]
55. Cells exhibiting strong
Liu JY; Souroullas GP; Diekman BO; Krishnamurthy J; Hall BM; Sorrentino JA; Parker JS; Sessions GA; Gudkov AV; Sharpless NE
Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2603-2611. PubMed ID: 30683717
[TBL] [Abstract][Full Text] [Related]
56. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
[TBL] [Abstract][Full Text] [Related]
57. Contrasting behavior of the p18INK4c and p16INK4a tumor suppressors in both replicative and oncogene-induced senescence.
Gagrica S; Brookes S; Anderton E; Rowe J; Peters G
Cancer Res; 2012 Jan; 72(1):165-75. PubMed ID: 22080569
[TBL] [Abstract][Full Text] [Related]
58. The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression.
Ohtani N; Yamakoshi K; Takahashi A; Hara E
J Med Invest; 2004 Aug; 51(3-4):146-53. PubMed ID: 15460900
[TBL] [Abstract][Full Text] [Related]
59. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
60. Involvement of the INK4a/Arf gene locus in senescence.
Collins CJ; Sedivy JM
Aging Cell; 2003 Jun; 2(3):145-50. PubMed ID: 12882406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
